Publications and Presentations

Book chapters, peer reviewed articles, other publications, abstract presentation and research grants.

Book Chapters

1. Benadiva CA, Kligman I, Rosenwaks Z: Assisted reproductive technologies versus tubal surgery. In: Sanfilippo JS (ed.) Operative Laparoscopy 2ed. Springer-Verlag, New York, 1995, p 278-305.

2. Rosenwaks Z, Kligman I, Benadiva CA, Davis O: Tubal Reconstructive Surgery. In: Mann WJ and Stovall TG (eds.), Gynecologic Surgery. Churchill-Livingston, New York, 1996, p 609-630.

3. Bremner T, Benadiva CA: Step-up protocols. In: Gautam Allahbadia (ed.), Manual of Ovulation Induction. Rotunda Medical Technologies, Bombay, India, 2001, p 51-57.

4. Benadiva C, Orris JJ: Preimplantation genetic diagnosis and assisted reproduction. In: Infertility and Reproductive Medicine Clinics of North America, 13 (2002) 489-505.

5. Orris JJ, Nulsen JC, Benadiva CA : Prevention strategies for ovarian hyperstimulation syndrome. In: Infertility and Reproductive Medicine Clinics of North America, 13 (2002) 459-474.

6. Schmidt D, Benadiva CA: Defining the poor ovarian response before controlled ovarian hyperstimulation. In: Gautam Allahbadia and Rita Basuray (eds.), The Art and Science of Assisted Reproductive Techniques. Jaypee Brothers Medical Publishers Ltd, 1st Edition, 2003, p 34-46.

7. Sueldo C, Nabel A, Glujovsky D, Sueldo C, Engmann L and Benadiva CA: “Induccion de la ovulacion para procedimientos de alta complejidad” (“Ovulation induction for high complexity procedures”). In Antonio Mackenna (Ed), Reproduccion Humana e Infertilidad. Editorial Mediterraneo, Santiago Chile 2012, P 423-429

8. Sueldo C, Nabel A, Glujovsky D, Sueldo C, Engmann L and Benadiva CA: “Induccion de la ovulacion para procedimientos de alta complejidad” (“Ovulation induction for high complexity procedures”). In Antonio Mackenna (Ed), Reproduccion Humana e Infertilidad. Editorial Mediterraneo, Santiago Chile 2012, P 423-429

9. Kaye L, Benadiva CA, Engmann L: Gonadotropin-releasing hormone agonist triggering. In Gardner, Weissman, Howles and Shoham (Eds), Textbook of Assisted Reproductive Techniques, Fifth Edition, Volume 2: Clinical Perspectives. ISBN 9781498740180 – CAT# K26678.

Peer-reviewed articles

1. Ben-Rafael Z, Benadiva CA, Barber B, Ausmanas M, Blasco L, Flickinger GL, Mastroianni L Jr: Dose of human menopausal gonadotropin influences the outcome of an in-vitro fertilization program. Fertil Steril, 48:964, 1987.

2. Ben-Rafael Z, Benadiva CA, García CJ, Flickinger GL: Cortisol stimulation of estradiol and progesterone secretion by human granulosa cells is independent of follicle-stimulating hormone effects. Fertil Steril, 49:813,1988.

3. Benadiva CA, Ben-Rafael Z, Strauss JF, Mastroianni L Jr, Flickinger GL: Ovarian response of individuals to different doses of human menopausal gonadotropin. Fertil Steril, 49:997, 1988.

4. Benadiva CA, Ben-Rafael Z, Blasco L, Tureck R, Mastroianni L Jr, Flickinger GL: Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives. Fertil Steril, 50:516, 1988.

5. Benadiva CA, Blasco L, Tureck R, Mastroianni L Jr, Flickinger GL: An increased initial FSH/LH ratio does not affect ovarian responses and the outcomes of IVF. Fertil Steril, 50:777,1988.

6. Ben-Rafael Z, Benadiva CA, Mastroianni L Jr, García CJ, Minda JM, Iozzo R, Flickinger GL: Collagen matrix influences the morphology and steroid secretion of human granulosa cells. Am J Obstet Gynecol, 159:1570-4, 1988.

7. Fateh M, Ben-Rafael Z, Benadiva CA, Mastroianni L Jr, Flickinger GL: Cortisol levels in human follicular fluid. Fertil Steril, 51:3, 1989.

8. Benadiva CA, Kuczynski-Brown B, Maguire TG, Mastroianni L Jr, Flickinger GL: Bovine serum albumin can replace patient serum as a protein source in an in-vitro fertilization program. J In Vitro Fertil Embryo Trans, 6:164, 1989.

9. Benadiva CA, Blasco L, Tureck R, Mastroianni L Jr, Flickinger GL: Comparison of different regimens of a GnRH analog during ovarian stimulation for in-vitro fertilization. Fertil Steril, 53:479,1990.

10. Benadiva CA, Metzger DA: Superovulation with human menopausal gonadotropins is associated with significant endometrial gland-stroma dyssynchrony. Fertil Steril, 61:700, 1994.

11. Albini SM, Benadiva CA, Haverly K, Luciano AA: Management of benign ovarian cystic teratomas: Laparoscopy compared with laparotomy. J Am Assoc Gynecol Lap, 1:219, 1994.

12. Kligman I, Noyes N, Benadiva CA, Rosenwaks Z: Massive deep vein thrombosis in a patient with antithrombin III deficiency undergoing ovarian stimulation for in-vitro fertilization. Fertil Steril, 63:673, 1995

13. Benadiva CA, Kligman I, Liu H-C, Davis O, Rosenwaks Z: Clomiphene citrate and human menopausal gonadotropin: an alternative stimulation protocol for selected failed in-vitro fertilization patients. J Assist Reprod Genet, 12:7, 1995

14. Benadiva CA, Kligman I, Davis O, Rosenwaks Z: In-vitro fertilization versus tubal surgery: is pelvic reconstructive surgery obsolete? Fertil Steril, 64:1051,1995

15. Benadiva CA, Kligman I, Munné S: Aneuploidy-16 in human embryos increases significantly with maternal age. Fertil Steril, 66:248,1996

16. Kligman I, Benadiva CA, Alikani M and Munne S: The presence of multinucleated blastomeres in human embryos is correlated with chromosomal abnormalities. Hum Reprod, 11:1492, 1996.

17. Benadiva CA, Moomjy M, Kligman I, Liu H-C, Davis O and Rosenwaks Z: Withholding gonadotropin administration is an effective alternative to cryopreservation of all embryos for the prevention of ovarian hyperstimulation syndrome. Fertil Steril, 67:724,1997.

18. Hoffman J, Laird L, Benadiva CA, Dreiss R: In vitro fertilization following conservative management of stage III serous borderline tumor of the ovary. Gynecol Oncol, 74:515-518, 1999.

19. Benadiva CA, Nulsen J, Siano L, Jennings J, Bet Givargis H and Maier D: Intracytoplasmic sperm injection overcomes previous fertilization failure with conventional in vitro fertilization. Fertil Steril, 72:1041, 1999.

20. Duffy DA, Nulsen J, Maier D, Schmidt D and Benadiva CA: Septate uterus with cervical duplication; a full term delivery after resection of a vaginal septum. Fertil Steril, 81:1125, 2004

21. Schmidt D, Maier D, Nulsen J and Benadiva CA: Reducing the dose of hCG in high responders does not affect the outcomes of in vitro fertilization. Fertil Steril, 82:841-846, 2004.

22. Duffy DA, Nulsen J, Maier D, Engmann L, Schmidt D and Benadiva CA: Obstetrical complications in gestational carrier pregnancies. Fertil Steril, 83:749-54,2005.

23. Engmann L, Schmidt D, Nulsen J, Maier D, and Benadiva CA: An unusual anatomical variation of a unicornuate uterus with a normal external uterine morphology. Fertil Steril, 82:950, 2004.

24. Schmidt D, Bremner T, Orris JJ, Maier D, Benadiva CA and Nulsen J: A randomized, prospective study of microdose leuprolide vs. ganirelix in IVF cycles for poor response patients. Fertil Steril, 83:1568, 2005.

25. Engmann L, Siano L, Schmidt D, Benadiva CA, Maier D and Nulsen J: The outcome of IVF treatment in patients who electively inseminate a limited number of oocytes to avoid creating surplus human embryos for cryopreservation. Fertil Steril, 84:1406, 2005.

26. Schmidt D, Engmann L, Siano L, Benadiva CA, Nulsen J and Maier D: Influence of embryo quality and number of previous cycles on pregnancy and multiple pregnancy rates in women aged 35 to 37 years who received two or three embryos. Fertil Steril, 84:1749, 2005.

27. Duffy DA, Manzi D, Benadiva CA, Maier D, Saunders M and Nulsen J: Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril, 85:407, 2006.

28. Engmann L, Siano L, Schmidt D, Nulsen J, Maier D and Benadiva CA: GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS. RBMOnline, 13:639-644, 2006

29. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D and Benadiva CA: The use of GnRH agonist to induce oocyte maturation after co-treatment with GnRH antagonist in high-risk patients undergoing IVF prevents the risk of OHSS: a prospective randomized controlled study. Fertil Steril, 2008;89-84-91.

30. Di Luigi A, Maier D and Benadiva CA: Ruptured ectopic pregnancy with contralateral adnexal torsion after spontaneous conception. Fertil Steril, 2008, 90:2007

31. Engmann L, Di Luigi A, Schmidt D, Benadiva CA, Maier D, and Nulsen J: The effect of luteal phase vaginal estradiol supplementation on the success of IVF treatment –a prospective randomized study. Fertil Steril, 2008; 89:554-61.

32. Weitzman V, Engmann L, DiLuigi A, Nulsen JC, Maier DB, and Benadiva CA: Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol (LPG) before gonadotropin stimulation versus standard microdose lupron protocol for patients with a history of poor IVF outcomes. Fertil Steril, 2009; 92:226-30.

33. Weitzman V, Schnee-Riesz J, Benadiva CA, Nulsen JC, Siano L and Maier DB: Predictive value of embryo grading for embryos with known outcomes. Fertil Steril, 2010; 93:658-62

34. Cetinkaya MB, Siano LJ, Benadiva CA, Sakkas D, and Patrizio P: Reproductive outcome of women 43 years and beyond undergoing ART treatment with their own oocytes in two Connecticut University programs. Journal Assist Reprod and Genetics, 2013; 30:673-678

35. Johnston-MacAnnany EB, Harnett J, Engmann L, Nulsen J, Sanders M and Benadiva CA: Chronic endometritis is a frequent finding in women with recurrent implantation failure. Fertil Steril, 2010; 93:437-41

36. Berin I, Engmann L, Benadiva CA, Schmidt DW, Nulsen J, and Maier DB: Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles. Fertil Steril, 2010; 93:355-9

37. Bromer J, Sakkas D, Siano LJ, Benadiva CA, and Patrizio P: Reproductive efficiency of women over age 40 and the low risk of multiple pregnancies. RBMOnline, 19:1, Suppl 4, 2009

38. DiLuigi AJ, Engmann L, Schmidt DW, Maier DB, Nulsen JC, and Benadiva CA: GnRH agonist to induce final oocyte maturation prevents the development of OHSS in high-risk patients and leads to improved clinical outcomes compared with coasting. Fertil Steril 2010; 94:1111-4

39. Mann J, Engmann L, Benadiva CA, and Nulsen J. Endogenous follicular gonadotropin flare in response to the microdose leuprolide flare stimulation protocol does not predict IVF success in poor responders. Fertil Steril 2010; 94:2427-9

40. Elassar A, Mann J, Engmann L, Nulsen J and Benadiva CA,. Luteal phase estradiol (LP) versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders. Fertil Steril, 95:324-26, 2011

41. DiLuigi AJ, Engmann L, Schmidt DW, Benadiva CA and Nulsen JC,: A randomized trial of microdose leuprolide protocol versus luteal phase ganirelix protocol in predicted poor responders. Fertil Steril 2011, 95:2531-3

42. Johnston-MacAnnany EB, DiLuigi A, Engmann L, Maier DB, Benadiva CA and Nulsen J: Selection of first IVF cycle stimulation protocol for good prognosis patients: GnRH antagonist versus agonist protocols. J Reprod Med 2011, 56:12-6

43. Elassar A, Engmann L, Nulsen J and Benadiva CA,. Letrozole and gonadotropins versus luteal estradiol and antagonist protocol in women with prior low response to ovarian stimulation. Fertil Steril 2011, 95:2330-4.

44. Kummer NE, Weitzman VN, Benadiva CA, Schmidt DW, Engmann L and Nulsen JC,: IVF outcomes in patients experiencing a premature rise in LH during a GnRH antagonist cycle. Fertil Steril 2011, 95:2592-4

45. Papanikolaou EG, Humaidan P, Polyzos NP, Kalantaridou S, Kol S, Tournaye H, Benadiva CA and Tarlatzis B: New Algorithm for OHSS prevention. Reproductive Biology and Endocrinology 2011, 9:147

46. Humaidan P, Kol S, Engmann L, Benadiva CA, Papanikolaou EG and Yding Andersen C: Should Cochrane reviews be performed during the development of new concepts? Human Reproduction 2012, 27:6

47. Humaidan P, Kol S, Papanikolaou EG on behalf of the “The Copenhagen GnRH Agonist triggering workshop group”: GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Human Reprod Update 2011, 17:510-24

48. Engmann L, Romak J, Nulsen J, Benadiva CA, and Peluso J: The in-vitro viability, and secretory capacity of human luteinized granulose cells after gonadotropin releasing hormone (GnRH) agonist trigger of oocyte maturation. Fertil Steril, 2011, 96:198-202.

49. Kummer NE, Benadiva CA, Feinn R, Mann J, Nulsen JC and Engmann L,: Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist. Fertil Steril 2011, 96:63-8.

50. Engmann L, and Benadiva CA: Agonist trigger: what is the best approach? Agonist trigger with aggressive luteal support. Fertil Steril 2012, 97:531

51. Griffin D, Benadiva CA, Kummer N, Budinetz T, Nulsen J and Engmann L, Dual trigger of oocyte maturation with GnRH agonist and low dose hCG to optimize live birth rates in high responders. Fertil Steril 2012, 97:1316-20

52. Kummer NE, Feinn R, Griffin DW, Nulsen JC, Benadiva CA and Engmann L,: Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist trigger. Hum Reprod 2013, 28:152-159

53. Copperman A and Benadiva CA: Optimal usage of the GnRH antagonists: a review of the literature. Reprod Biology and Endocrinology, 2013, 11:20

54. Siano L, Nulsen J, Engmann L and Benadiva CA,: Prospective pilot study comparing fertilization and embryo development between fresh and vitrified sibling oocytes. Connecticut Medicine, 2013, 77:211-8

55. Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T and Benadiva CA,, Dual trigger with gonadotropin releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril 2014, 102:405-9

56. Elassar A, Nulsen J, Engmann L and Benadiva CA,. Estradiol and antagonist pretreatment prior to microdose leuprolide in IVF. Does it improve IVF outcomes in poor responders as compared to OCP? The Journal of Reprod Medicine 2015, 60:199-204.

57. Budinetz TH, Mann JS, Griffin DW, Benadiva CA, Nulsen JC and Engmann LL: Maternal and neonatal outcomes after GnRH agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization. Fertil Steril 2014, 102:753-8.

58. Sueldo C, Budinetz T, Maslow BS, Nulsen J, Engmann L and Benadiva CA,. Concurrent ovarian and ipsilateral tubal ectopic pregnancies after a double embryo transfer: a case report. J Assist Reprod Genet 2014, 31:1643-1646.

59. Budinetz TH, Benadiva CA, Griffin DW, Engmann LL, Nulsen JC and DiLuigi A: Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol. Fertil Steril 2015, 103:675-9.

60. Kol S, Humaidan P, Alsbjerg B, Engmann L, Benadiva CA, Garcia-Velasco JA, Fatemi H and Yding Andersen C: The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors. RBOnline 2015, 30:563-565.

61. Humaidan P, Engmann L, and Benadiva CA: Luteal phase supplementation after GnRH agonist trigger in fresh embryo transfer: the American versus European approaches. Fertil Steril 2015; 103:879-85.

62. Maslow B-S, Budinetz TH, Sueldo C, Anspach E, Engmann LL, Benadiva CA, and Nulsen JC: Single nucleotide polymorphism-microarray ploidy analysis of paraffin-embedded products of conception in recurrent pregnancy loss evaluations. Obstet Gynecol 2015, 126 (1):175-81.

63. Kaye L, Sueldo C, Engmann LL, Nulsen JC and Benadiva CA,: A survey assessing obesity policies for assisted reproductive technology in the United States. Fertil Steril, 2016; 105:703-6.

64. Maslow B-S, Bartolucci A, Sueldo C, Engmann LL, Benadiva CA, and Nulsen JC: Occult abnormal pregnancies after first post-embryo transfer serum beta-hCG levels between 1.0 and 5.0 mIU/mL. Fertil Steril 2016, 105:938-945

65. Engmann L, Benadiva CA and Humaidan P: GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles – A SWOT analysis. RBOnline, 2016, 32:274-285.

66. Sueldo C, Kaye L, Griffin D, Nulsen JC, Engmann LL, and Benadiva CA,: Ultrashort flare GnRH agonist with GnRH antagonist (MDA/Ant) protocol compared with Clomiphene Citrate/gonadotropins (CC/Gnd) for poor responder patients. JFIV Reprod Med Genet 4:179.doi:10.4172/2375-4508.1000179

67. Maslow B, Davis S, Engmann L, Nulsen J, Benadiva CA: Correlation of Normal-Range FMR1 Repeat Length or Genotypes and Reproductive Parameters. J Assist Reprod Genet 2016, 33:9, 1149-1155.

68. Carpinello O, Jacob MC, Nulsen J, Benadiva C: Assisted Reproductive Technologies: Utilization of fertility treatment and reproductive choices by lesbian couples. Fertil Steril 2016; 106:1709-13.

69. Kaye L, Bartels C, Bartolucci A, Engmann LL, Nulsen JC and Benadiva CA: Old habits die hard: Retrospective analysis of outcomes with use of corticosteroids and antibiotics prior to embryo transfer. Fertil Steril 2017,107:1336-40.

70. Kaye L, Anspach-Will E, Bartolucci AF, Nulsen JC, Benadiva CA and Engmann LL: Pregnancy rates for single embryo transfer (SET) of day 5 and day 6 blastocysts after cryopreservation by vitrification and slow freeze. Journal of Assisted Reproduction and Genetics 2017, 34:913.

71. Griffin D, Benadiva CA, Budinetz T, Sueldo C, DiLuigi A, Nulsen J, and Engmann L: The dual trigger study: Rationale and study design of a prospective double-blind randomized clinical trial comparing pregnancy rates after co-administration of low dose hCG at the time of GnRH agonist trigger or 35 h later for the prevention of OHSS. Contemporary Clinical Trials Communications 8 (2017) 18-24.

72. Kaye L, Marsidi A, Rai P, Thorne JT, Nulsen J, Engmann L and Benadiva CA: Frozen blastocyst transfer outcomes in immediate versus delayed subsequent cycles following GnRH agonist or hCG triggers. Journal of Assisted Reproduction and Genetics 2018, 35:669-675.

73. Benadiva CA and Engmann L: Luteal phase support after GnRH-a triggering, does is still matter? Fertil Steril 2018, 109:763-767.

74. Engmann LL, Maslow BS, Kaye LA, Griffin DW, DiLuigi AJ, Schmidt DW, Grow DR, Nulsen JC and Benadiva CA: Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial. J Ovarian Res. 2019 Jan 26;12(1):8. doi: 10.1186/s13048-019-0483-7.

75. Thorne J, Loza A, Kaye LA, Griffin DW, Nulsen JC, Benadiva CA, Grow D and Engmann L: Euploidy rates between cycles triggered with gonadotropin releasing hormone agonist and hCG. Fertil Steril, 2019; 112:258-65.

76. Bartels C, Ditrio L, Grow D, O’Sullivan MD, Benadiva CA, Engmann L and Nulsen JC: The window is wide: flexible timing for frozen-thawed embryo transfer in natural cycles. RBOnline, 2019; 39:241-48.

77. Kaye L, Thorne JT, Neuber E, Nulsen J, Benadiva CA and Engmann L: Independent serum markers of corpora lutea function after GnRH agonist trigger and adjuvant low dose hCG in IVF. Fertil Steril, 2019;112:534-44.

78. Makhijani RB, Thorne J, Bartels C, Bartolucci A, Nulsen J, Grow D, Benadiva CA, and Engmann: Pregnancy outcomes after frozen-thawed single euploid blastocyst transfer following IVF cycles using GnRH agonist or hCG trigger for final oocytes maturation. Journal of Assisted Reproduction and Genetics, 2020;37:611-617, https://doi.org/10.1007/s10815-019-01646-z

79. Makhijani RB, Bartels C, Godiwala P, Bartolucci A, Nulsen J, Grow D, Benadiva CA, and Engmann L: Maternal and perinatal outcomes in programmed versus natural vitrified-thawed blastocyst transfer cycles. RBOnline 2020,41:300-308.

80. Bartels C, Makhijani RB, Godiwala P, Bartolucci A, Nulsen J, Grow D, Engmann L and Benadiva CA: IVF outcomes after preimplantation genetic testing for chromosomal structural rearrangements (PGT-SR) comparing fluorescence in-situ hybridization (FISH), microarray comparative genomic hybridization (aCGH) and next generation sequencing (NGS). Fertil Steril Rep, 2020, 1:249-56.

81. Makhijani RB, Bartels C, Godiwala P, Bartolucci A, DiLuigi A, Nulsen J, Grow D, Benadiva CA, and Engmann L: Impact of trophectoderm biopsy on obstetric and perinatal outcomes following frozen-thawed embryo transfer cycles. Hum Reprod, 2021, 36:340-348

82. Makhijani RB, Coulter M, Taggar A, Godiwala P, O’Sullivan D, Nulsen J, Engmann L, Benadiva CA, and Grow D: Reduction in multiple pregnancy rate in donor oocyte-recipient gestational carrier (GC) in vitro fertilization (IVF) cycles in the Unites States with single embryo transfer and preimplantation genetic testing. Journal of Assisted Reproduction and Genetics, in press,

Other Publications

Duffy DA, and Benadiva CA: Letters-to-the –Editor, Fertil Steril, 82: 767-768 ,2004.

Engmann L, and Benadiva CA: GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Letters-to-the –Editor, Hum Reprod, 20:3258-60, 2005.

3. Engmann L and Benadiva CA: Ovarian hyperstimulation syndrome prevention strategies: luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger. Seminars in Reproductive Medicine, Volume 28, Number 6, 2010, 506-12.

4. Rosenwaks Z and Benadiva CA: Ovarian hyperstimulation: a preventable syndrome? Seminars in Reproductive Medicine, Volume 28, Number 6, 2010, 437-9.

5. Rosenwaks Z and Benadiva CA: An eye to the future. Seminars in Reproductive Medicine, Volume 28, Number 6, 2010, 540.

Elassar A, and Benadiva CA: Letrozole + GnRH antagonist protocol early LH rise and cost-effectiveness. Reply to Letters-to-the –Editor, Fertil Steril 2011, 9:e80.

Humaidan P, Kol S, Papanikolaou EG, Engmann L, Benadiva CA, Itskovitz-Eldor J, Margalioth EJ, Ricciarelly E, Bodri D, Castillo-Farfan JC, Garacia-Vezasco JA, Yding Andersen C, Deveroy P and Tarlatzis B: “GnRH agonist for triggering of final oocyte maturation: time for a critical evaluation of data. Letters-to-the –Editor, Hum Reprod Update, 18 (2):229-230, 2012.

Benadiva CA, Engmann L: Intensive luteal phase support after GnRH agonist trigger: it does help. Letters-to-the-Editor, RBOnline 2012, 25,329-330.

Abstract Presentations

1. Alonso R, Lopez G, Benadiva CA, Medvetzky L, Stefanic F. Premature labor in low socio-economical levels; our experience. Oral Presentation: 2nd Scientific Meeting of the Buenos Aires Society of Obstetrics and Gynecology, Buenos Aires, Argentina, October 1982.

2. Lopez G, Medvetzky L, Benadiva CA, Mormandi JO: Abortion at the Castex Hospital, period 1980/83. Oral Presentation: The 1st Obstetrics and Gynecology Workshop of the Buenos Aires Society of Obstetrics and Gynecology, Buenos Aires, Argentina, July 1983.

3. Mormandi J, Guman N, Berardi E, Sadier E, Luengo C, Benadiva CA, D’Ambrossi M: Neoplasia of the uterine cervix in the pregnant-puerperal state. Oral Presentation: The 29th Annual Meeting of the Argentine Society of Uterine-Cervical Pathology and Colposcopy, Buenos Aires, Argentina, September 1984.

4. Gonzalez R, Platas S, Benadiva CA, D’Ambrossi M, Cei M: Tap-test, a new method to evaluate the fetal pulmonary maturity. Oral Presentation: The 2nd National Meeting of the Buenos Aires Society of Obstetrics and Gynecology, Bahia Blanca, Argentina, November 1984.

5. Ben-Rafael Z, Benadiva CA, Barber B, Ausmanas M, Blasco L, Flickinger GL and Mastroianni L Jr.: Dose of human menopausal gonadotropin influences the outcome of an in-vitro fertilization program. Poster Presentation: The Vth World Congress on IVF-ET, Norfolk, Virginia, April 1987. Published in program supplement, p 35.

6. Benadiva CA, Ben-Rafael Z, García CJ, Mastroianni L Jr, Flickinger GL: Ovarian response of individuals to different doses of human menopausal gonadotropin. Oral Presentation: The 43rd Annual Meeting of the American Fertility Society, Reno, Nevada, September 1987. Published in Program Supplement, p 24.

7. Benadiva CA, Ben-Rafael Z, Blasco L, Tureck R, Mastroianni L Jr, Flickinger GL: Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives. Poster Presentation: The Society for Gynecologic Investigation Annual Meeting, Baltimore, Maryland, March 1988. Published in Scientific Program, p 132.

8. Benadiva CA, Blasco L, Tureck R, Mastroianni L Jr, Flickinger GL: Ovarian stimulation with an increased initial FSH/LH ratio does not affect the outcome of in-vitro fertilization. Poster Presentation: The Society for Gynecologic Investigation 35th Annual Meeting, Baltimore, Maryland, March 1988. Published in Scientific Program , p 133.

9. Benadiva CA, Kuczynski-Brown B, Mastroianni L Jr and Flickinger GL: Bovine serum albumin can replace patient’s serum as a protein source in an in-vitro fertilization program. Oral Presentation: The 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 1988. Published in Program Supplement, p 40.

10. Fiszbajn G, Benadiva CA, Tureck R, Flickinger GL and Blasco L: Usefulness of standard semen analysis in predicting fertilization in an IVF program. Poster Presentation: The 44th Annual Meeting of the American Fertility Society, Atlanta, Georgia, October 1988. Published in Program Supplement, p 99.

11. Benadiva CA, Blasco L, Tureck R, Mastroianni L Jr and Flickinger GL: Differences in early response to a GnRH analog influence the outcome of in-vitro fertilization. Poster Presentation: The Society for Gynecologic Investigation 36th Annual Meeting, San Diego, California, March 1989. Published in Scientific Program , p 309.

12. Kligman I, Benadiva CA, Blasco L. Tureck R, Mastroianni L Jr and Flickinger GL: Different timing of hCG administration after an endogenous LH surge affects fertilization and outcomes of IVF. Poster Presentation: The VIth World Congress of IVF and Alternate Assisted Reproduction, Jerusalem, Israel, April 1989. Published in the Abstracts Book, p 156.

13. Flickinger GL, Benadiva CA, Sondheimer SJ, Tureck R and Blasco L: Comparison of different regimens of a GnRH agonist during ovarian stimulation for in-vitro fertilization. Oral Presentation: The VIth World Congress of IVF and Alternate Assisted Reproduction, Jerusalem, Israel, April 1989. Published in the Abstracts Book, p 12.

14. Benadiva CA, Blasco L, Tureck R, Mastroianni L Jr, Flickinger GL: Follicular recruitment is enhanced by the additional stimulatory effect of a GnRH analog during the early follicular phase. Oral Presentation: The 45th Annual Meeting of the American Fertility Society, San Francisco, California, November 1989. Published in the Abstracts Book, S 39.

15. Benadiva CA, Nulsen JC, Metzger DA: Superovulation with human menopausal gonadotropins is associated with significant endometrial gland-stroma dyssynchrony. Poster Presentation: The 48th Annual Meeting ot the American Fertility Society, New Orleans, Lousiana, November 2-5, 1992. Published in the Abstracts Book, S151.

16. Benadiva CA, Metzger DA: Immunohistochemical assessment of estrogen and progesterone receptor content in endometrial biopsies from women with endometrial gland-stroma dyssynchrony associated with hMG superovulation. Oral Presentation: The 49th Annual Meeting of The American Fertility Society and the 39th Annual Meeting of the Canadian Fertility and Andrology Society, Montreal, Quebec, Canada, October 1993.

17. Albini SM, Metzger DA, Oktay K, Benadiva CA, Luciano AA, Chere M: Laparoscopic retropubic urethral suspension. Oral Presentation: The International Congress of the European Society of Human Reproduction and Embryology, Goreme-Kapadokya, Turkey, May 1993.

18. Albini SM, Metzger DA, Benadiva CA, Haverly K, Luciano AA: Laparoscopic management of ovarian benign cystic teratomas. Oral Presentation: The World Congress of Gynecologic Endoscopy, AAGL 22nd Annual Meeting, San Francisco, California, November 1993.

19. Benadiva CA, Kligman I, Liu H-C, Neal GS, Sultan KM, Noyes N, Rosenwaks Z: Clomiphene citrate and human menopausal gonadotropin: A rescue stimulation protocol for selected failed in-vitro fertilization patients. Poster Presentation: The 50th Annual Meeting of the American Fertility Society, San Antonio, Texas, November 1994.

20. Benadiva CA, Kligman I, Moy F, Neal GS, Sultan KM, Liu H-C, Rosenwaks Z: Cumulative probability of pregnancy after in-vitro fertilization in tubal factor infertility. Poster Presentation: The 50th Annual Meeting of the American Fertility Society, San Antonio, Texas, November 1994.

21. Sultan KM, Neal GS, Cholst I, Kligman I, Benadiva CA, Noyes N, Davis OK, Rosenwaks Z: Uterine factors influence implantation rate in an oocyte donation program. Oral Presentation: The 50th Annual Meeting of the American Fertility Society, San Antonio, Texas, November 1994.

22. Catz DS, Benadiva CA, Liu H-C, Rosenwaks Z: Potential role of leukemia inhibitory factor (LIF) in the differentiation of the human endometrium. Poster Presentation: The 34th Annual Meeting of the American Society for Cell Biology, San Francisco, California, December 1994.

23. Benadiva CA, Kligman I, Liu H-C, Damario M, Moomjy M, Moy F, Rosenwaks Z. Implantation efficiency in women over age 40 is independent of the magnitude of the ovarian response. Oral presentation: The Society for Gynecologic Investigation 42nd Annual Meeting, Chicago, Illinois, March 1995.

24. Benadiva CA, Kruger T, Kligman I, Sultan KM, Feliciano M and Rosenwaks Z. Sperm morphology does not correlate with fertilization rates in normal male partners of egg donor recipients. Poster presentation: The IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3-7, 1995.

25. Kligman I, Noyes N, Benadiva CA, Liu H-C, Moy F, Sultan KM and Rosenwaks Z. Progesterone level on the day of hCG in stimulated cycles for IVF does not influence endometrial thickness, endometrial pattern or IVF outcome. Oral presentation: The IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3-7, 1995.

26. Kligman I, Benadiva CA , Feliciano M, Moy F, Rosenwaks Z and Palermo G. Immunofluorescent detection of acrosin is more reliable than sperm morphology in predicting fertilizing ability in vitro. Oral presentation: The IXth World Congress on In Vitro Fertilization and Assisted Reproduction, Vienna, April 3-7, 1995.

27. Benadiva CA, Moomjy M, Kligman I, Liu H-C, Davis O and Rosenwaks Z: Withholding gonadotropin administration is an effective alternative to cryopreservation of all embryos for the prevention of ovarian hyperstimulation syndrome. Poster presentation: The 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 7-12, 1995.

28. Benadiva CA, Munné S and Rosenwaks Z: Chromosome 16 aneuploidy increases significantly with maternal age in preimplantation human embryos. Recipient of the Society of Assisted Reproductive Technologies (SART) Prize Paper Award, 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 7-12, 1995.

29. Munné S, Benadiva CA, Cohen J and Grifo J: Results of 12 cases of preimplantation diagnosis of aneuploidy in women 40 years or older. Oral Presentation: The 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 7-12, 1995.

30. Kligman I, Witkin SS, Benadiva CA, Rosenwaks Z and Palermo G: Intracytoplasmic sperm injection (ICSI) is the treatment of choice for immunological infertility. Poster presentation: The 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, Washington, October 7-12, 1995.

31. Shwartzman S, Benadiva CA, Sammartino L, Grifo J, and Rosenwaks Z: Anticardiolipin antibodies and infertility. Presented at the 1995 National Scientific Meeting of the American College of Rheumatology, San Francisco, California, October 22-26, 1995.

32. Esposito MA, Benadiva CA, Luciano AA: Tubal cannulation as a treatment for proximal tubal occlusion: hysteroscopic versus fluoroscopic approach. Poster presentation: The 53rd Annual Meeting of the American Society for Reproductive Medicine, Cincinnatti, Ohio, October 18-22, 1997.

33. Benadiva CA, Siano L, Jenning J, Betgivargis H, Luciano AA: Intracytoplasmic sperm injection (ICSI) overcomes previous fertilization failure with conventional in vitro fertilization (IVF). Poster presentation: IFFS ‘98/ 54th Annual Meeting of the American Society for Reproductive Medicine, San Francisco, CA, October 3-9, 1998.

34. Luciano AA, Miller BE, Sequenzia LC, Benadiva CA, Slade KL and De Souza MJ: The pharmacokinetics of the sublingual administration of micronized estradiol, progesterone and testosterone in postmenopausal women. Poster presentation: IFFS ‘98/ 54th Annual Meeting of the American Society for Reproductive Medicine, San Francisco, CA, October 3-9, 1998.

35. Luciano AA, Miller BE, Sequenzia LC, Benadiva CA, Slade KL and De Souza MJ: Effects of the sublingual administration of micronized estradiol, progesterone and testosterone on bone metabolism in postmenopausal women. Presented at the Second Joint Meeting of the ASBMR and IBMS, December 1-6, San Francisco, CA, 1998.

36. Luciano AA, Miller BE, Sequenzia LC, Benadiva CA, Slade KL and De Souza MJ: The effects of sublingual micronized estradiol, progesterone and testosterone on menopausal symptoms and sexual health. Presented at the Second Joint Meeting of the ASBMR and IBMS, December 1-6, San Francisco, CA, 1998.

37. Luciano AA, Miller BE, Sequenzia LC, Benadiva CA, Slade KL and De Souza MJ: The effects of sublingual micronized estradiol, progesterone and testosterone on serum lipids and apolipoproteins. Presented at the Second Joint Meeting of the ASBMR and IBMS, December 1-6, San Francisco, CA, 1998.

38. Luciano AA, Miller BE, Sequenzia LC, Benadiva CA, Slade KL and De Souza MJ: The effects of sublingual micronized estradiol, progesterone and testosterone on pro-coagulant and anti-coagulant factors. Presented at the Second Joint Meeting of the ASBMR and IBM